Literature DB >> 6210424

Serotonergic receptor subtypes and vascular reactivity.

J M Van Nueten, J E Leysen, F de Clerck, P M Vanhoutte.   

Abstract

Two distinct binding sites for serotonin have been identified in brain tissue and labeled 5-HT1 and 5-HT2 binding sites. The receptor mediating contractions of several types of vascular smooth muscle (including the canine basilar artery), aggregation of blood platelets, and contractions of tracheal muscle can be defined as a 5-HT2 serotonergic receptor. The prejunctional inhibitory effect of serotonin on adrenergic neurotransmission is mediated by receptors which have the same affinity for agonists as the 5-HT1 binding sites. The other peripheral actions of serotonin, in particular its vasodilator effects and its excitatory effects on gastrointestinal smooth muscle, do not involve 5-HT2 serotonergic receptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210424     DOI: 10.1097/00005344-198406004-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  15 in total

Review 1.  Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

2.  Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.

Authors:  D S Houston; J T Shepherd; P M Vanhoutte
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

3.  Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1).

Authors:  H Frances; C Bulach; P Simon; M Fillion; G Fillion
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

4.  Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.

Authors:  R A Cohen
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

5.  Oral sarpogrelate can improve endothelial dysfunction as effectively as oral cilostazol, with fewer headaches, in active young male smokers.

Authors:  Il Soon Jeong; Jae-Hyeong Park; Seon Ah Jin; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  Heart Vessels       Date:  2012-09-12       Impact factor: 2.037

6.  A-FABP and oxidative stress underlie the impairment of endothelium-dependent relaxations to serotonin and the intima-medial thickening in the porcine coronary artery with regenerated endothelium.

Authors:  Calvin K Chan; Yingzi Zhao; Song Yan Liao; Yue Lin Zhang; Mary Y K Lee; Aimin Xu; Hung Fat Tse; Paul M Vanhoutte
Journal:  ACS Chem Neurosci       Date:  2012-09-22       Impact factor: 4.418

7.  Cold-induced Raynaud's phenomenon ameliorated by intravenous administration of ketanserin: a double-blind cross-over study.

Authors:  H Baart de la Faille; H van Weelden; J D Banga; R G van Kesteren
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

Review 8.  Serotonergic antagonists and vascular disease.

Authors:  P M Vanhoutte
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 9.  Serotonin and the vascular system. Role in health and disease, and implications for therapy.

Authors:  D S Houston; P M Vanhoutte
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

10.  Receptor-mediated effects of serotonin and 5-methoxytryptamine on noradrenaline release in the rat vena cava and in the heart of the pithed rat.

Authors:  M Göthert; E Schlicker; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.